Aktiesnakken — Januar 2024
-
According to Cramer, health-care companies can yield bigger percentage gains than tech companies, for which investors should be looking. He also pointed out the large number of multibillion-dollar biopharma acquisitions announced at the end of 2023, saying investors should be on the lookout for more industry mergers.
-
Tirsdagens danske avisuddrag med Vestas, Pandora og Genmab https://www.proinvestor.com/investornyt/1100847/tirsdagens-danske-avisuddrag-med-vestas-pandora-og-genmab
-
Shortpositioner på danske aktier tirsdag d. 9. januar 2024 https://www.proinvestor.com/boards/117876
-
Gut Mørnings

-
Mornings
-
@TheNote gad for Matas?
-
glad..
-
Matas Group upgrades its guidance for the financial year 2023/24 as follows:
Group total revenue is now expected in the range of DKK 6,650-6,750 million (previously DKK 6,400-6,600 million)
-
Kilde: GlobeNewswire
-
tak @TheNote - happy too
-
Matas Q3: Opjusterer efter stærkt julesalg og valutamedvind https://www.proinvestor.com/investornyt/1100873/matas-q3-opjusterer-efter-staerkt-julesalg-og-valutamedvind
-
Morgan Stanley ser europæiske aktier komme tilbage i plus: Negang er midlertidig https://www.proinvestor.com/investornyt/1100950/morgan-stanley-ser-europaeiske-aktier-komme-tilbage-i-plus-negang-er-midlertidig
-
Danske Bank hæver kursmålet på Matas til 160 fra 150, gentager Køb
-
Godmorgen

-
Godmorgen

-
Svak nedgang på New York-børsen
S&P 500 og Dow Jones indeksene sank tirsdag, etter av en beskjeden økning i amerikanske statsobligasjoner.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind